FDA Drug Application (202362) for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202362
Product Number001
FormTABLET;ORAL
Dosage62.5MG;25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Active IngredientATOVAQUONE; PROGUANIL HYDROCHLORIDE



Back to FDA Applications sponsored by MYLAN PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.